EICHOR
● Enrolling By Invitation
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
Condition: Biliary Atresia · Sponsor: Albireo, an Ipsen Company
About this study
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (30)
| Children's Hospital Colorado | Aurora, Colorado, United States | — |
| Children's Healhcare of Atlanta- Emory University school of medicine | Atlanta, Georgia, United States | — |
| Indiana University school of Medicine | Indianapolis, Indiana, United States | — |
| Boston Children's Hospital | Boston, Massachusetts, United States | — |
| Children's Mercy Hospital and Clinics | Kansas City, Missouri, United States | — |
| Hassenfeld Children's Hospital at NYU Langone | New York, New York, United States | — |
| Columbia University Medical Center New York Presbyterian Morgan Stanley-Komansky Childrens Hospital | New York, New York, United States | — |
| The Childrens Hospital at Montefiore Albert Einstein School of Medicine | The Bronx, New York, United States | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | — |
| Seattle Children's Hospital | Seattle, Washington, United States | — |
| Royal Children's Hospital | Parkville, Australia | — |
| CHU Sainte-Justine | Montreal, Canada | — |
+ 18 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05426733